- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
Détention brevets de la classe C07K 14/34
Brevets de cette classe: 509
Historique des publications depuis 10 ans
|
23
|
37
|
52
|
37
|
37
|
63
|
40
|
46
|
38
|
30
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| CJ Cheiljedang Corporation | 3679 |
143 |
| Ajinomoto Co., Inc. | 2283 |
22 |
| Glaxosmithkline Biologicals S.A. | 1599 |
15 |
| Daesang Corporation | 380 |
14 |
| Ningxia Eppen Biotech Co., Ltd | 48 |
13 |
| Evonik Operations GmbH | 4404 |
11 |
| Pfizer Inc. | 3414 |
9 |
| National Research Council of Canada | 1551 |
7 |
| Scarab Genomics, LLC | 38 |
7 |
| Wake Forest University Health Sciences | 730 |
7 |
| Fina BioSolutions, LLC | 21 |
6 |
| Scott & White Memorial Hospital | 9 |
6 |
| Wyeth LLC | 601 |
5 |
| The Governors of the University of Alberta | 875 |
5 |
| Jiangnan University | 1639 |
5 |
| Korea University Research and Business Foundation | 3299 |
5 |
| The Regents of the University of Colorado, a body corporate | 2841 |
5 |
| The Scripps Research Institute | 1345 |
5 |
| Biological e Limited | 72 |
5 |
| Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences | 131 |
4 |
| Autres propriétaires | 210 |